Related Experiment Video
Updated: May 16, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Multifunctional quinoline-based hydrazones as promising antidiabetic agents: experimental and computational insights
Aditi Kalakwade1, Rohini S Kavalapure1, Shankar Gharge1
1Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher education and Research, Belagavi 591124, Karnataka, India.
New quinoline-based hydrazones show promise as multifunctional antidiabetic agents. These compounds target key enzymes and pathways involved in diabetes, demonstrating potential for improved therapies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Traditional antidiabetic agents often target single pathways, leading to limitations.
- Developing multifunctional agents offers a promising strategy for more effective diabetes treatment.
- Quinoline derivatives have shown potential, but exploration of novel scaffolds like hydrazones is needed.
Purpose of the Study:
- To design and synthesize novel quinoline-based hydrazone analogues.
- To evaluate their potential as multifunctional antidiabetic agents targeting α-glucosidase, α-amylase, and PPAR-γ.
- To investigate the structure-activity relationships and molecular interactions of these compounds.
Main Methods:
- Synthesis of a library of quinoline-based hydrazone analogues (7a-7j).
- In vitro enzymatic assays to determine inhibitory activity against α-glucosidase and α-amylase.
- Cell-based assays to assess PPAR-γ transcriptional activity.
- Molecular docking and dynamics simulations for in silico analysis.
- In silico ADMET prediction for pharmacokinetic properties.
Main Results:
- Compounds 7e and 7h displayed potent α-glucosidase inhibition (IC50 values in the low micromolar range), comparable to acarbose.
- Compound 7g exhibited strong α-amylase inhibition (IC50: 7.85 ± 1.92 μM).
- Compounds 7b and 7f significantly enhanced PPAR-γ transcriptional activity, suggesting insulin-sensitizing effects.
- Molecular simulations confirmed stable interactions with target proteins.
- In silico ADMET analysis indicated acceptable permeability and oral absorption, though solubility needs optimization.
Conclusions:
- Quinoline-based hydrazones represent a promising class of multifunctional antidiabetic agents.
- The designed analogues effectively inhibit key enzymes and modulate relevant pathways in diabetes.
- Further in vivo studies are warranted to explore their therapeutic potential.
- Optimization of physicochemical properties may enhance their clinical applicability.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Sulfonylureas
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
